Hims & Hers Health, Inc. (HIMS) vs Ligand Pharmaceuticals Incorporated (LGND)

A side-by-side comparison of Hims & Hers Health, Inc. and Ligand Pharmaceuticals Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HIMS vs LGND

growth of $100 · dividends reinvested · last 7y
HIMS +202.8% (+17.1%/yr)LGND +470.1% (+28.2%/yr)LGND compounded faster over this window
0200400600Start $100202120232025$303$570
HIMS LGND

HIMS vs LGND: by the numbers

  • •HIMS is the larger company ($6.51B vs $5.90B market cap).
  • •LGND is profitable (67.88% net margin) while HIMS runs a net loss (-5.51%).
  • •HIMS grew revenue faster over the past five years (67.47% vs 2.92% CAGR).

Metrics side by side

Valuation

MetricHIMSLGND
P/E ratioN/A31.51
Forward P/EN/A31.66
P/S ratio2.5220.32
P/B ratio20.086.10
EV / EBITDAN/A44.67
FCF yield1.38%2.22%

Profitability

MetricHIMSLGND
Gross margin73.84%98.58%
Operating margin4.50%17.61%
Net margin-5.51%67.88%
ROE-43.83%20.38%
ROIC-4.30%3.91%

Growth (annualized)

MetricHIMSLGND
Revenue CAGR (5Y)67.47%2.92%
FCF CAGR (5Y)N/A-0.49%
Total return CAGR (5Y)32.23%30.72%

Frequently asked

Which has grown faster, HIMS or LGND?
Over the past five years, HIMS grew revenue faster — HIMS at a 67.47% CAGR versus LGND at 2.92%.
Is HIMS or LGND more profitable?
LGND runs the higher net margin — HIMS at -5.51% versus LGND at 67.88%.
How have HIMS and LGND total returns compared?
Over the past 5 years, HIMS delivered 32.23% and LGND delivered 30.72% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.